These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28615273)

  • 1. Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
    Turner KM; Christensen H; Adams EJ; McAdams D; Fifer H; McDonnell A; Woodford N
    BMJ Open; 2017 Jun; 7(6):e015447. PubMed ID: 28615273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.
    Harding-Esch EM; Huntington SE; Harvey MJ; Weston G; Broad CE; Adams EJ; Sadiq ST
    Euro Surveill; 2020 Oct; 25(43):. PubMed ID: 33124553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agent-based modelling study of antimicrobial-resistant Neisseria gonorrhoeae transmission in men who have sex with men: towards individualised diagnosis and treatment.
    Zienkiewicz AK; Verschueren van Rees N; Homer M; Ong JJ; Christensen H; Hill D; Looker KJ; Horner P; Hughes G; Turner KME
    Sex Health; 2019 Sep; 16(5):514-522. PubMed ID: 31476277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing a model to predict individualised treatment for gonorrhoea: a modelling study.
    Findlater L; Mohammed H; Gobin M; Fifer H; Ross J; Geffen Obregon O; Turner KME
    BMJ Open; 2021 Jun; 11(6):e042893. PubMed ID: 34172543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge.
    Unemo M
    BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
    Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM
    Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
    Riou J; Althaus CL; Allen H; Cole MJ; Grad YH; Heijne JCM; Unemo M; Low N
    BMC Infect Dis; 2023 Apr; 23(1):252. PubMed ID: 37081443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.
    Unemo M; Golparian D; Eyre DW
    Methods Mol Biol; 2019; 1997():37-58. PubMed ID: 31119616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
    Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
    BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).
    Vandepitte J; Hughes P; Matovu G; Bukenya J; Grosskurth H; Lewis DA
    Sex Transm Dis; 2014 Apr; 41(4):233-7. PubMed ID: 24622633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
    Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
    J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
    Selb R; Jansen K; Eckardt M; Tamminga T; Dudareva S; Gassowski M; Graeber I; Guhl E; Heuer D; Buder S;
    BMC Infect Dis; 2020 Jul; 20(1):514. PubMed ID: 32677988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial-resistant gonorrhoea: the national public health response, England, 2013 to 2020.
    Merrick R; Cole M; Pitt R; Enayat Q; Ivanov Z; Day M; Sun S; Sinka K; Woodford N; Mohammed H; Fifer H
    Euro Surveill; 2022 Oct; 27(40):. PubMed ID: 36205171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.